233 related articles for article (PubMed ID: 36012492)
1. Prostate Cancer Secretome and Membrane Proteome from
Santos NJ; Camargo ACL; Carvalho HF; Justulin LA; Felisbino SL
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012492
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
[TBL] [Abstract][Full Text] [Related]
3. Mucinous metaplasia in Pten conditional knockout mice and mucin family genes as prognostic markers for prostate cancer.
Santos NJ; Ximenes PP; Constantino FB; Carvalho HF; Felisbino SL
Life Sci; 2022 Mar; 293():120264. PubMed ID: 35031262
[TBL] [Abstract][Full Text] [Related]
4. miR-410-3p promotes prostate cancer progression via regulating PTEN/AKT/mTOR signaling pathway.
Zhang Y; Zhang D; Lv J; Wang S; Zhang Q
Biochem Biophys Res Commun; 2018 Sep; 503(4):2459-2465. PubMed ID: 29969630
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
Nip H; Dar AA; Saini S; Colden M; Varahram S; Chowdhary H; Yamamura S; Mitsui Y; Tanaka Y; Kato T; Hashimoto Y; Shiina M; Kulkarni P; Dasgupta P; Imai-Sumida M; Tabatabai ZL; Greene K; Deng G; Dahiya R; Majid S
Oncotarget; 2016 Oct; 7(42):68371-68384. PubMed ID: 27634912
[TBL] [Abstract][Full Text] [Related]
6. Exosome-derived microRNAs contribute to prostate cancer chemoresistance.
Li J; Yang X; Guan H; Mizokami A; Keller ET; Xu X; Liu X; Tan J; Hu L; Lu Y; Zhang J
Int J Oncol; 2016 Aug; 49(2):838-46. PubMed ID: 27278879
[TBL] [Abstract][Full Text] [Related]
7. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases.
Dülgeroğlu Y; Eroğlu O
Microrna; 2020; 9(4):303-309. PubMed ID: 33155933
[TBL] [Abstract][Full Text] [Related]
8. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
[TBL] [Abstract][Full Text] [Related]
9. A basal-enriched microRNA is required for prostate tumorigenesis in a Pten knockout mouse model.
Fan X; Bjerke GA; Riemondy K; Wang L; Yi R
Mol Carcinog; 2019 Dec; 58(12):2241-2253. PubMed ID: 31512783
[TBL] [Abstract][Full Text] [Related]
10. Co-expression network analysis identified hub genes critical to triglyceride and free fatty acid metabolism as key regulators of age-related vascular dysfunction in mice.
Li H; Wang X; Lu X; Zhu H; Li S; Duan S; Zhao X; Zhang F; Alterovitz G; Wang F; Li Q; Tian XL; Xu M
Aging (Albany NY); 2019 Sep; 11(18):7620-7638. PubMed ID: 31514170
[No Abstract] [Full Text] [Related]
11. Proteomic and transcriptomic profiling of Pten gene-knockout mouse model of prostate cancer.
Zhang J; Kim S; Li L; Kemp CJ; Jiang C; Lü J
Prostate; 2020 May; 80(7):588-605. PubMed ID: 32162714
[TBL] [Abstract][Full Text] [Related]
12. Comparative expression profiles of host circulating miRNAs in response to Trichinella spiralis infection.
Ma XH; Ren HJ; Peng RY; Li Y; Ming L
Vet Res; 2020 Mar; 51(1):39. PubMed ID: 32156309
[TBL] [Abstract][Full Text] [Related]
13. Adipose tissue from metabolic syndrome mice induces an aberrant miRNA signature highly relevant in prostate cancer development.
Massillo C; Duca RB; Lacunza E; Dalton GN; Farré PL; Taha N; Piccioni F; Scalise GD; Gardner K; De Siervi A
Mol Oncol; 2020 Nov; 14(11):2868-2883. PubMed ID: 32875710
[TBL] [Abstract][Full Text] [Related]
14. A unique insight into the MiRNA profile during genital chlamydial infection.
Benyeogor I; Simoneaux T; Wu Y; Lundy S; George Z; Ryans K; McKeithen D; Pais R; Ellerson D; Lorenz WW; Omosun T; Thompson W; Eko FO; Black CM; Blas-Machado U; Igietseme JU; He Q; Omosun Y
BMC Genomics; 2019 Feb; 20(1):143. PubMed ID: 30777008
[TBL] [Abstract][Full Text] [Related]
15. Tear miRNAs Identified in a Murine Model of Sjögren's Syndrome as Potential Diagnostic Biomarkers and Indicators of Disease Mechanism.
Kakan SS; Edman MC; Yao A; Okamoto CT; Nguyen A; Hjelm BE; Hamm-Alvarez SF
Front Immunol; 2022; 13():833254. PubMed ID: 35309364
[TBL] [Abstract][Full Text] [Related]
16. Identification of the microRNA expression profile in the regenerative neonatal mouse heart by deep sequencing.
Liu HL; Zhu JG; Liu YQ; Fan ZG; Zhu C; Qian LM
Cell Biochem Biophys; 2014 Sep; 70(1):635-42. PubMed ID: 24756729
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of PTEN-related ceRNA network revealing the key pathways WDFY3-AS2 - miR-21-5p/miR-221-3p/miR-222-3p - TIMP3 as potential biomarker in tumorigenesis and prognosis of kidney renal clear cell carcinoma.
Zhou X; Liu G; Xu M; Ying X; Li B; Cao F; Cheng S; Xiao B; Cheng M; Liang L; Jia M; Li W; Liu J; Li Z
Mol Carcinog; 2022 May; 61(5):508-523. PubMed ID: 35129856
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN.
Duan XM; Liu XN; Li YX; Cao YQ; Silayiding A; Zhang RK; Wang JP
Kaohsiung J Med Sci; 2019 Nov; 35(11):659-671. PubMed ID: 31332950
[TBL] [Abstract][Full Text] [Related]
19. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
[TBL] [Abstract][Full Text] [Related]
20. Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease.
Selth LA; Townley S; Gillis JL; Ochnik AM; Murti K; Macfarlane RJ; Chi KN; Marshall VR; Tilley WD; Butler LM
Int J Cancer; 2012 Aug; 131(3):652-61. PubMed ID: 22052531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
